» Articles » PMID: 38789721

Fluorescence Tracking Demonstrates T Cell Recirculation is Transiently Impaired by Radiation Therapy to the Tumor

Abstract

T cells recirculate through tissues and lymphatic organs to scan for their cognate antigen. Radiation therapy provides site-specific cytotoxicity to kill cancer cells but also has the potential to eliminate the tumor-specific T cells in field. To dynamically study the effect of radiation on CD8 T cell recirculation, we used the Kaede mouse model to photoconvert tumor-infiltrating cells and monitor their movement out of the field of radiation. We demonstrate that radiation results in loss of CD8 T cell recirculation from the tumor to the lymph node and to distant sites. Using scRNASeq, we see decreased proliferating CD8 T cells in the tumor following radiation therapy resulting in a proportional enrichment in exhausted phenotypes. By contrast, 5 days following radiation increased recirculation of T cells from the tumor to the tumor draining lymph node corresponds with increased immunosurveillance of the treated tumor. These data demonstrate that tumor radiation therapy transiently impairs systemic T cell recirculation from the treatment site to the draining lymph node and distant untreated tumors. This may inform timing therapies to improve systemic T cell-mediated tumor immunity.

Citing Articles

A novel small molecule Enpp1 inhibitor improves tumor control following radiation therapy by targeting stromal Enpp1 expression.

Baird J, Alice A, Saito R, Chai Q, Han M, Ng C Sci Rep. 2024; 14(1):29913.

PMID: 39622844 PMC: 11612208. DOI: 10.1038/s41598-024-80677-8.

References
1.
Mortimer P, Simmonds R, Rezvani M, Robbins M, Ryan T, Hopewell J . Time-related changes in lymphatic clearance in pig skin after a single dose of 18 Gy of X rays. Br J Radiol. 1991; 64(768):1140-6. DOI: 10.1259/0007-1285-64-768-1140. View

2.
Seo W, Shimizu K, Kojo S, Okeke A, Kohwi-Shigematsu T, Fujii S . Runx-mediated regulation of CCL5 via antagonizing two enhancers influences immune cell function and anti-tumor immunity. Nat Commun. 2020; 11(1):1562. PMC: 7099032. DOI: 10.1038/s41467-020-15375-w. View

3.
Miller B, Sen D, Al Abosy R, Bi K, Virkud Y, LaFleur M . Subsets of exhausted CD8 T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. 2019; 20(3):326-336. PMC: 6673650. DOI: 10.1038/s41590-019-0312-6. View

4.
Medler T, Kramer G, Bambina S, Gunderson A, Alice A, Blair T . Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help. Sci Rep. 2023; 13(1):6277. PMC: 10113239. DOI: 10.1038/s41598-023-33508-1. View

5.
Kwon S, Janssen C, Velasquez F, Zhang S, Aldrich M, Shaitelman S . Radiation Dose-Dependent Changes in Lymphatic Remodeling. Int J Radiat Oncol Biol Phys. 2019; 105(4):852-860. DOI: 10.1016/j.ijrobp.2019.07.054. View